{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:34:43Z","timestamp":1783488883598,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eprac.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:47:48Z","timestamp":1747122468000},"page":"987-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Continuous Subcutaneous Hydrocortisone Infusion in Adrenal Insufficiency: Practical Experience in 33 Subjects"],"prefix":"10.1016","volume":"31","author":[{"given":"Jane","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Mirfakhraee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2025.05.004_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.004_bib2","doi-asserted-by":"crossref","first-page":"e2851","DOI":"10.1210\/clinem\/dgac175","article-title":"Quality of life and its determinants in patients with adrenal insufficiency: a survey study at 3 centers in the United States","volume":"107","author":"Li","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.05.004_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.918356","article-title":"High mortality rate in oral glucocorticoid users: a population-based matched cohort study","volume":"13","author":"Einarsdottir","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.004_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","article-title":"Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency","volume":"61","author":"Mah","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.004_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1517\/17425255.4.6.749","article-title":"Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors","volume":"4","author":"Lennernas","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.004_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.13837","article-title":"Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy","volume":"90","author":"Dineen","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.004_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cen.12670","article-title":"Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy","volume":"83","author":"Bjornsdottir","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.004_bib8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.05.004_bib9","article-title":"Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients","volume":"2015","author":"Khanna","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.eprac.2025.05.004_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5315059","article-title":"Patients with hypocortisolism treated with continuous subcutaneous hydrocortisone infusion (CSHI): an option for poorly controlled patients","volume":"2023","author":"Mortensen","year":"2023","journal-title":"Int J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.004_bib11","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1210\/jc.2014-2433","article-title":"Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.004_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison's disease","volume":"157","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.004_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12020-018-1780-4","article-title":"Continuous subcutaneous hydrocortisone infusion in a woman with secondary adrenal insufficiency","volume":"63","author":"Cardini","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.004_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/03014460801908439","article-title":"Estimating body surface area from mass and height: theory and the formula of Du Bois and Du Bois","volume":"35","author":"Burton","year":"2008","journal-title":"Ann Hum Biol"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.004_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/S0022-3476(03)00294-4","article-title":"Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency","volume":"143","author":"Punthakee","year":"2003","journal-title":"J Pediatr"},{"issue":"4 Suppl","key":"10.1016\/j.eprac.2025.05.004_bib16","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.004_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eprac.2025.05.004_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.718660","article-title":"Sex-specific limitations in physical health in primary adrenal insufficiency","volume":"12","author":"Didriksen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.004_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/jc.2011-1901","article-title":"Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL","volume":"97","author":"Oksnes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.004_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11154-024-09905-w","article-title":"Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review","volume":"25","author":"Alekrish","year":"2024","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T19:07:31Z","timestamp":1756753651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1530891X25001466"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.004","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous Subcutaneous Hydrocortisone Infusion in Adrenal Insufficiency: Practical Experience in 33 Subjects","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}